Hepatic Steatosis and Fibrosis in Rheumatoid Arthritis Patients

Evaluation of Hepatic Steatosis and Fibrosis in Rheumatoid Arthritis Patients: a Cross-sectional Case-control Study

studying the prevalence of hepatic steatosis and fibrosis in a large scale of patients with RA and healthy controls

Inclusion Criteria:

1. RA according to the American College of Rheumatology (ACR)/EULAR 2010 criteria (Aletaha et al., 2010)
2. Age≥18 years

Exclusion Criteria:

• History of hepatitis B and C virus infection.
• Receiving hepatotoxic drugs other than RA-specific drugs.
• Alcohol abuse (i30 g/day in men and ⩾20 g/day in women).
• Diagnosis of Wilson's disease, α1-antitrypsin deficiency or hemochromatosis.
• Autoimmune liver disease.
• Cancer.
• Pregnancy.